Ms Patty Murphy, MA, LMFT | |
Pmb 907 Box 10001, Saipan, MP 96950 | |
(670) 287-1200 | |
Not Available |
Full Name | Ms Patty Murphy |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | Pmb 907 Box 10001, Saipan, Northern Mariana Islands |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992020275 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 18338-0001-2 (Northern Mariana Islands) | Primary |
106H00000X | Marriage & Family Therapist | MFC14989 (California) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Ms Patty Murphy, MA, LMFT Pmb 907 Box 10001, Saipan, MP 96950 Ph: (670) 287-1200 | Ms Patty Murphy, MA, LMFT Pmb 907 Box 10001, Saipan, MP 96950 Ph: (670) 287-1200 |
News Archive
Recent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer Society guidelines recommending screening in that age group, according to a new study.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its nasopharyngeal swab and toehold switch technologies have been licensed to Alabama-based Agile Biodetection, which will use them to develop solutions for unmet diagnostic needs in the detection of the SARS-CoV-2 virus in environmental or clinical settings.
UC Irvine biologists, chemists and computer scientists have identified an elusive pocket on the surface of the p53 protein that can be targeted by cancer-fighting drugs. The finding heralds a new treatment approach, as mutant forms of this protein are implicated in nearly 40 percent of diagnosed cases of cancer, which kills more than half a million Americans each year.
Kyruus, a leading provider of Patient Access & Referral Management Solutions, announced today that it has partnered with University Hospitals in Cleveland, Ohio, to deploy its ProviderMatch platform.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
› Verified 5 days ago